Products
Tuberculosis
Rapid and comprehensive tuberculosis diagnostics - the need of the hour
Tuberculosis (TB) is an infectious disease caused by members of the Mycobacterium tuberculosis complex (MTBC). TB primarily affects the lungs, yet it also spreads to other parts of the body. The
health of affected patients gradually deteriorates, eventually leading to death if left untreated.
TB is one of the top 10 causes of death worldwide. It is also the main killer related to antimicrobial resistance and among carriers of HIV. Around 10 million people contract tuberculosis globally each
year. A total of 1.25 million people died from tuberculosis (TB) in 2023.
Tuberculosis is curable when the right antibiotic therapy is given to the patient. With resistance now prevalent, the key is early and precise diagnosis of the disease. The gold standard for TB diagnosis is culture, but it is very slow. Diagnosis based solely on culture, therefore, delays the correct therapy for weeks, thus endangering the patient as well as increasing the risk of spreading antibiotic resistant forms of TB.
Current practices have led to the rise of even more deadly forms of the infections known as MDR-TB, XDR-TB and TDR-TB2. These multi-resistant strains require quick identification, otherwise their spread will
accelerate.
At Clemedi we are developing a diagnostic solution that identifies disease-causing Mycobacteria and predicts antibiotic susceptibility to several antibiotics - all of this within 24 hours!
Our new products thus save lives and prevents further spread of mycobacterial resistance.
1 – https://www.who.int/news-room/fact-sheets/detail/tuberculosis
2 – MDR – multidrug resistant, XDR – extremely drug resistant, TDR – totally drug resistant